Barbara D Powe1. 1. Special Populations Research, Behavioral Research Center, American Cancer Society, Atlanta, Georgia 30329, USA.
Abstract
PURPOSE: The purpose of this experimental study was to test the effectiveness of a multiphasic culturally relevant intervention, delivered over a 1-year period to increase the rates of participation in fecal occult blood testing (FOBT) at the initial screening opportunity and at the 1-year follow-up screening opportunity among rural African American women. DESCRIPTION OF STUDY: The study used a pretest/post-test design among African American women who attended senior citizen centers in a rural southern state. The centers were randomly assigned to the cultural and self-empowerment group, who received the five-phased intervention, the modified cultural group, who received phase I of the intervention only, or the traditional group, who served as the control group. Data were collected at the initial and 1-year follow-up screenings. Hemoccult kits were distributed, collected, and analyzed at no cost to the participants. Data were analyzed using descriptive statistics, repeated measures, and longitudinal models for binary outcomes. RESULTS: Women in the cultural and self-empowerment group had a significantly higher rate of participation in FOBT than did those in the modified cultural group and the traditional group. The modified cultural group had a significantly higher rate of participation in FOBT than the did the traditional group. Predictors of participation in FOBT were the women's family history of colorectal cancer and the average number of visits to their healthcare provider. CLINICAL IMPLICATIONS: Colorectal cancer screening and diagnostic testing opportunities should be offered consistently to women who visit their provider for routine, nonemergent office visits. As successful interventions to increase colorectal cancer screening are introduced into community settings, these interventions also should be tested within physicians' offices and other community agencies.
RCT Entities:
PURPOSE: The purpose of this experimental study was to test the effectiveness of a multiphasic culturally relevant intervention, delivered over a 1-year period to increase the rates of participation in fecal occult blood testing (FOBT) at the initial screening opportunity and at the 1-year follow-up screening opportunity among rural African American women. DESCRIPTION OF STUDY: The study used a pretest/post-test design among African American women who attended senior citizen centers in a rural southern state. The centers were randomly assigned to the cultural and self-empowerment group, who received the five-phased intervention, the modified cultural group, who received phase I of the intervention only, or the traditional group, who served as the control group. Data were collected at the initial and 1-year follow-up screenings. Hemoccult kits were distributed, collected, and analyzed at no cost to the participants. Data were analyzed using descriptive statistics, repeated measures, and longitudinal models for binary outcomes. RESULTS:Women in the cultural and self-empowerment group had a significantly higher rate of participation in FOBT than did those in the modified cultural group and the traditional group. The modified cultural group had a significantly higher rate of participation in FOBT than the did the traditional group. Predictors of participation in FOBT were the women's family history of colorectal cancer and the average number of visits to their healthcare provider. CLINICAL IMPLICATIONS: Colorectal cancer screening and diagnostic testing opportunities should be offered consistently to women who visit their provider for routine, nonemergent office visits. As successful interventions to increase colorectal cancer screening are introduced into community settings, these interventions also should be tested within physicians' offices and other community agencies.
Authors: Charles E Basch; Randi L Wolf; Corey H Brouse; Celia Shmukler; Alfred Neugut; Lawrence T DeCarlo; Steven Shea Journal: Am J Public Health Date: 2006-10-31 Impact factor: 9.308
Authors: Thomas D Denberg; Trisha V Melhado; John M Coombes; Brenda L Beaty; Kenneth Berman; Tim E Byers; Alfred C Marcus; John F Steiner; Dennis J Ahnen Journal: J Gen Intern Med Date: 2005-11 Impact factor: 5.128
Authors: Clement K Gwede; Emmanuel Jean-Francois; Gwendolyn P Quinn; Shaenelle Wilson; Will L Tarver; Kamilah B Thomas; Susan T Vadaparampil; Cathy D Meade Journal: J Natl Med Assoc Date: 2011-08 Impact factor: 1.798
Authors: D R Sullivan; C W Forsberg; L Ganzini; D H Au; M K Gould; D Provenzale; K S Lyons; C G Slatore Journal: Lung Cancer Date: 2016-08-16 Impact factor: 5.705
Authors: Judith M E Walsh; René Salazar; Jonathan P Terdiman; Ginny Gildengorin; Eliseo J Pérez-Stable Journal: J Gen Intern Med Date: 2005-12 Impact factor: 5.128
Authors: Katherine N DuHamel; Elizabeth A Schofield; Cristina Villagra; Pathu Sriphanlop; Steven H Itzkowitz; Gina Cotter; Noah Cohen; Deborah O Erwin; Gary Winkel; Hayley S Thompson; Ann G Zauber; Lina H Jandorf Journal: Cancer Date: 2019-11-19 Impact factor: 6.860
Authors: Hosanna Soler-Vilá; Robert Dubrow; Vivian I Franco; Andrea K Saathoff; Stanislav V Kasl; Beth A Jones Journal: Cancer Date: 2009-09-15 Impact factor: 6.860